FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135032077> ?p ?o ?g. }

• W2135032077 endingPage "e56" @default.
• W2135032077 startingPage "e56" @default.
• W2135032077 abstract "Objective. To assess the effects of antiretroviral combination therapy that contains protease inhibitor (PI) on carbohydrate and lipid metabolism in human immunodeficiency virus (HIV)-infected children. Methods. A cross-sectional, descriptive clinical study was conducted in an outpatient clinic. Thirty-seven HIV-infected children who ranged from 1 to 17 years of age received nucleoside reverse transcriptase inhibitor treatment together with PI (PI group, n = 25) or without PI (non-PI group, n = 12). Age, gender, weight, length, CD4 cell count, and viral load did not differ between groups. Nonfasting total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, glucose, lactate, and blood gases were determined. In addition, c-peptide, insulin, hemoglobin A1c, free fatty acids, lipoprotein a, and apolipoproteins A1 and B were evaluated after fasting. PI and non-PI group values were compared with normal values taken from healthy children. Results. In nonfasting and fasting conditions, children of the PI group had higher total cholesterol (fasting PI group: 235 ± 71 mg/dL; non-PI group: 176 ± 25 mg/dL, mean ± standard deviation), triglycerides (156 ± 89 vs 87 ± 31 mg/dL), and LDL cholesterol levels (159 ± 58 vs 113 ± 23 mg/dL) compared with the non-PI group. High-density lipoprotein cholesterol and apolipoprotein A1 levels did not differ in both groups; there was a trend toward higher apolipoprotein B levels in the PI group. After fasting, 8 (47%) of 17 patients in the PI group presented with hypercholesterolemia as a result of an increase of LDL cholesterol and 11 (65%) had hypertriglyceridemia. It is interesting that the non-PI group showed no pathologic deviations. Compared with normal values, lipoprotein a and free fatty acids were increased in the PI and non-PI groups. Glucose, lactate, blood gases, c-peptide, insulin, and hemoglobin A1c were normal in both groups. Conclusion. PI-containing antiretroviral treatment of HIV-infected children was associated with hypercholesterolemia, hypertriglyceridemia, and an increase of LDL cholesterol. The long-term complications of dyslipidemia are of major concern in the growing HIV-infected child." @default.
• W2135032077 created "2016-06-24" @default.
• W2135032077 creator A5045822524 @default.
• W2135032077 creator A5062304818 @default.
• W2135032077 creator A5068637996 @default.
• W2135032077 creator A5076479264 @default.
• W2135032077 creator A5085393215 @default.
• W2135032077 date "2002-11-01" @default.
• W2135032077 modified "2023-10-14" @default.
• W2135032077 title "Marked Dyslipidemia in Human Immunodeficiency Virus-Infected Children on Protease Inhibitor-Containing Antiretroviral Therapy" @default.
• W2135032077 cites W1501152217 @default.
• W2135032077 cites W1968842162 @default.
• W2135032077 cites W1971054353 @default.
• W2135032077 cites W1976890976 @default.
• W2135032077 cites W1977705956 @default.
• W2135032077 cites W1978444406 @default.
• W2135032077 cites W1978724449 @default.
• W2135032077 cites W1998660799 @default.
• W2135032077 cites W2031732862 @default.
• W2135032077 cites W2032026322 @default.
• W2135032077 cites W2034385594 @default.
• W2135032077 cites W2035864434 @default.
• W2135032077 cites W2056243308 @default.
• W2135032077 cites W2060210361 @default.
• W2135032077 cites W2061496424 @default.
• W2135032077 cites W2062515126 @default.
• W2135032077 cites W2076562284 @default.
• W2135032077 cites W2084332399 @default.
• W2135032077 cites W2085560533 @default.
• W2135032077 cites W2117654000 @default.
• W2135032077 cites W2148825772 @default.
• W2135032077 cites W2149568397 @default.
• W2135032077 cites W2160696982 @default.
• W2135032077 cites W2318289184 @default.
• W2135032077 cites W2324473093 @default.
• W2135032077 cites W2516626610 @default.
• W2135032077 cites W4237136736 @default.
• W2135032077 doi "https://doi.org/10.1542/peds.110.5.e56" @default.
• W2135032077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12415062" @default.
• W2135032077 hasPublicationYear "2002" @default.
• W2135032077 type Work @default.
• W2135032077 sameAs 2135032077 @default.
• W2135032077 citedByCount "74" @default.
• W2135032077 countsByYear W21350320772012 @default.
• W2135032077 countsByYear W21350320772013 @default.
• W2135032077 countsByYear W21350320772014 @default.
• W2135032077 countsByYear W21350320772015 @default.
• W2135032077 countsByYear W21350320772016 @default.
• W2135032077 countsByYear W21350320772017 @default.
• W2135032077 countsByYear W21350320772019 @default.
• W2135032077 countsByYear W21350320772020 @default.
• W2135032077 countsByYear W21350320772021 @default.
• W2135032077 countsByYear W21350320772023 @default.
• W2135032077 crossrefType "journal-article" @default.
• W2135032077 hasAuthorship W2135032077A5045822524 @default.
• W2135032077 hasAuthorship W2135032077A5062304818 @default.
• W2135032077 hasAuthorship W2135032077A5068637996 @default.
• W2135032077 hasAuthorship W2135032077A5076479264 @default.
• W2135032077 hasAuthorship W2135032077A5085393215 @default.
• W2135032077 hasBestOaLocation W21350320771 @default.
• W2135032077 hasConcept C126322002 @default.
• W2135032077 hasConcept C134018914 @default.
• W2135032077 hasConcept C142462285 @default.
• W2135032077 hasConcept C203014093 @default.
• W2135032077 hasConcept C2778096610 @default.
• W2135032077 hasConcept C2778163477 @default.
• W2135032077 hasConcept C2778913445 @default.
• W2135032077 hasConcept C2780072125 @default.
• W2135032077 hasConcept C2780745583 @default.
• W2135032077 hasConcept C2781143361 @default.
• W2135032077 hasConcept C2993143319 @default.
• W2135032077 hasConcept C3013748606 @default.
• W2135032077 hasConcept C555293320 @default.
• W2135032077 hasConcept C62746215 @default.
• W2135032077 hasConcept C71924100 @default.
• W2135032077 hasConcept C90924648 @default.
• W2135032077 hasConceptScore W2135032077C126322002 @default.
• W2135032077 hasConceptScore W2135032077C134018914 @default.
• W2135032077 hasConceptScore W2135032077C142462285 @default.
• W2135032077 hasConceptScore W2135032077C203014093 @default.
• W2135032077 hasConceptScore W2135032077C2778096610 @default.
• W2135032077 hasConceptScore W2135032077C2778163477 @default.
• W2135032077 hasConceptScore W2135032077C2778913445 @default.
• W2135032077 hasConceptScore W2135032077C2780072125 @default.
• W2135032077 hasConceptScore W2135032077C2780745583 @default.
• W2135032077 hasConceptScore W2135032077C2781143361 @default.
• W2135032077 hasConceptScore W2135032077C2993143319 @default.
• W2135032077 hasConceptScore W2135032077C3013748606 @default.
• W2135032077 hasConceptScore W2135032077C555293320 @default.
• W2135032077 hasConceptScore W2135032077C62746215 @default.
• W2135032077 hasConceptScore W2135032077C71924100 @default.
• W2135032077 hasConceptScore W2135032077C90924648 @default.
• W2135032077 hasIssue "5" @default.
• W2135032077 hasLocation W21350320771 @default.
• W2135032077 hasLocation W21350320772 @default.
• W2135032077 hasOpenAccess W2135032077 @default.
• W2135032077 hasPrimaryLocation W21350320771 @default.
• W2135032077 hasRelatedWork W196644465 @default.

• next